BrCa cells treated with CXCL16 also showed decreased GSK3B-mediated phosphorylation of B catenin Ser37, which suggests increased B-catenin stability, which in turn would support survival, EMT, and metastasis. This evidence concerns the gene GSK3B and invasive breast carcinoma.